Amantadine: legal
This page summarises amantadine's status in the places checked; it is not legal advice, and it does not cover every country or state.
United States
Amantadine is an approved medicine. A current generic label reads: “Amantadine hydrochloride tablets are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus” and “Amantadine hydrochloride tablets are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions”.[1] An extended-release brand, Gocovri, is labelled “For the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy”.[2]
It does not appear by name anywhere in the federal “Schedules of Controlled Substances”, read in full on 2026-11-19.[3] State law was not checked for this page.
Sport
The World Anti-Doping Agency's list, which states “This List shall come into effect on 1 January 2026.”, does not name amantadine.[4]
References
- Amantadine hydrochloride tablets, US prescribing information (ANDA076186), DailyMed, read 2026-11-19 — US National Library of Medicine (DailyMed), label as submitted to the FDA
- Gocovri (amantadine) extended-release capsules, US prescribing information, via openFDA drug labels, read 2026-11-19 — US Food and Drug Administration (openFDA)
- 21 CFR part 1308, Schedules of Controlled Substances, full text as of 2026-11-13 (eCFR versioner, read 2026-11-19) — US Drug Enforcement Administration, via eCFR (National Archives)
- World Anti-Doping Code International Standard: Prohibited List 2026, Wayback capture of 19 November 2026 — World Anti-Doping Agency
Comments
Sign in to join the conversation.
No comments yet.